Agilon Health (NYSE:AGL) Trading Up 8.5% – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL)’s stock price was up 8.5% during mid-day trading on Friday . The company traded as high as $96.08 and last traded at $96.4180. Approximately 54,065 shares changed hands during trading, a decline of 85% from the average daily volume of 357,666 shares. The stock had previously closed at $88.90.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Barclays set a $111.00 target price on shares of Agilon Health and gave the stock an “equal weight” rating in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Wells Fargo & Company restated an “overweight” rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a report on Tuesday. Benchmark reiterated a “buy” rating and issued a $140.00 price target (up from $95.00) on shares of Agilon Health in a report on Thursday, August 6th. Finally, TD Cowen reissued a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Agilon Health currently has a consensus rating of “Hold” and an average target price of $86.18.

Agilon Health Trading Up 8.7%

The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The business’s 50-day simple moving average is $106.88 and its two-hundred day simple moving average is $58.31. The company has a market capitalization of $1.62 billion, a PE ratio of -6.77 and a beta of 3.01.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. On average, analysts predict that Agilon Health, Inc. will post -2.95 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

A number of institutional investors have recently made changes to their positions in AGL. North Peak Capital Management LLC grew its position in shares of Agilon Health by 10.8% during the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after buying an additional 3,715,460 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Agilon Health by 196.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares in the last quarter. AQR Capital Management LLC raised its holdings in Agilon Health by 1,346.6% in the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Agilon Health by 30.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after acquiring an additional 1,893,434 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Agilon Health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock valued at $4,944,000 after acquiring an additional 35,054 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.